![]() |
市場調査レポート
商品コード
1800908
ナノロボティクス市場レポート:タイプ、用途、エンドユーザー、地域別、2025年~2033年Nanorobotics Market Report by Type, Application, End User, and Region 2025-2033 |
||||||
カスタマイズ可能
|
ナノロボティクス市場レポート:タイプ、用途、エンドユーザー、地域別、2025年~2033年 |
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 136 Pages
納期: 2~3営業日
|
世界のナノロボティクス市場規模は2024年に78億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに180億米ドルに達し、2025年から2033年にかけて9.29%の成長率(CAGR)を示すと予測しています。個別化ヘルスケアへのシフトの高まり、有効性向上のための調査事業への投資の増加、より効率的で低侵襲な選択肢を提供するためのがん治療での使用の増加は、市場成長を促す要因の一部です。
精密医療への需要の高まり
個別化ヘルスケアへのシフトは、市場成長を促す重要な要因の1つです。ナノロボットは、精密医療の目的に沿って、細胞や分子のスケールで病気を特定し、対処する上で比類のない精度を提供します。これらのデバイスは、特定の細胞や組織を特異的にターゲットとして設計することができ、健康な細胞への害を最小限に抑えることができます。低侵襲(MI)処置に対する需要の高まりにより、ナノロボットはドラッグデリバリー、組織修復、病気の早期発見といった複雑な医療介入において好ましいソリューションとなっています。人体内で高精度に動作するナノロボットの能力は、医療用途の開発への関心と投資を高めています。IMARC Groupのデータによると、2023年の精密医療の世界市場規模は752億米ドルでした。
ナノ医療への投資の増加
政府機関や民間団体は、ナノロボットが治療に革命をもたらす可能性を認識しており、研究開発(R&D)への注目すべき投資につながっています。この資金調達により、特定部位への薬物送達、遺伝子治療、即時診断など、さまざまな医療用途向けのナノロボットの開発、有効性、機能が強化されています。製薬業界は、精密医療の進歩や複雑な処置におけるナノロボットの利用の増加により、創薬や開発にナノロボティクスを取り入れることに強い関心を示しています。臨床試験で良好な結果が得られたことから、ナノロボットへの投資が増加し、医療用途への導入が加速し、市場成長に寄与しています。2024年、シカゴ大学の研究者たちによって、腫瘍付近の血管の透過性を高めることで、マウスの腫瘍への化学療法薬のデリバリーを改善する新しいナノメディシンが生み出されました。STING活性化剤と化学療法を組み合わせたこの新たな戦略は、腫瘍増殖の顕著な抑制と治癒の成功を示し、研究チームは前臨床試験を目指すことになりました。
がん治療研究の高まり
ナノロボットは、がん細胞を特異的に見つけて除去するために作られつつあり、化学療法や放射線のような従来の治療と比較して、より効率的で侵襲性の低い選択肢を提供しています。抗がん剤を腫瘍部位に直接送達し、健康な組織を温存することで、ナノロボットは副作用を軽減し、患者の転帰を改善します。これに加えて、これらのデバイスは、がんの初期症状を特定するために使用され、タイムリーな介入行動を可能にしています。ナノロボットは、腫瘍学分野において、がん細胞を正確に標的化し制御するため、がん治療において極めて重要なツールです。がんは依然として健康上の大きな課題であり、そのため腫瘍学へのナノロボット応用研究が活発化しています。2024年、尿素を動力源とするナノマシンを利用したカタルーニャ生物工学研究所(IBEC)の科学者たちによって、膀胱がんの治療における大きな進歩が明らかにされました。このナノロボットはマウスで実験され、表面に付着した放射性同位元素を使って腫瘍を特異的に攻撃するため、1回の治療で腫瘍サイズを90%縮小させることができました。
The global nanorobotics market size reached USD 7.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 18.0 Billion by 2033, exhibiting a growth rate (CAGR) of 9.29% during 2025-2033. The growing shift towards personalized healthcare, rising investments in research operation to improve effectiveness and the increasing use in cancer therapies to provide a more efficient and less invasive option are some of the factors impelling the market growth.
Growing Demand for Precision Medicine
The shift towards personalized healthcare represents one of the key factors impelling the market growth. Nanorobots provide unparalleled precision in identifying and addressing illnesses at the cellular and molecular scales, in line with the objectives of precision medicine. These devices can be designed to specifically target certain cells or tissues, minimizing harm to healthy cells, which is crucial in the treatment of cancer. The growing demand for minimally invasive (MI) procedures is making nanorobots a preferred solution in complex medical interventions such as drug delivery, tissue repair, and early disease detection. The ability of nanorobots to operate within the human body with high precision is increasing interest and investment in their development for medical applications. In 2023, the worldwide market for precision medicine was valued at US$ 75.2 Billion, according to the data provided by the IMARC Group.
Increasing Investments in Nanomedicine
Governing bodies and private organizations are recognizing the potential of nanorobots to revolutionize medical treatments, leading to notable investments in research and development (R&D). The funding is enhancing the development, effectiveness, and features of nanorobots for different medical uses, like delivering drugs to specific areas, gene therapy, and immediate diagnosis. The pharmaceutical industry is showing strong interest in incorporating nanorobotics into drug discovery and development due to advancements in precision medicine and the growing utilization of nanorobots in complex procedures. The increasing positive outcomes from clinical trials is resulting in higher investments in nanorobots, speeding up their introduction into medical applications and contributing to the market growth. In 2024, a new nanomedicine was created by University of Chicago researchers to improve the delivery of chemotherapy drugs to tumors in mice by enhancing the permeability of blood vessels near the tumors. This fresh strategy, combining STING activators with chemotherapy, demonstrated notable suppression of tumor growth and successful curing, leading the team to aim for preclinical trials.
Rise in Cancer Treatment Research
Nanorobots are being created to specifically locate and eliminate cancer cells, providing a more efficient and less invasive option compared to conventional treatments like chemotherapy and radiation. By delivering anti-cancer drugs directly to tumor sites and sparing healthy tissues, nanorobots reduce side effects and improve patient outcomes. Besides this, these devices are being used to identify initial symptoms of cancer, enabling timely intervention action. Nanorobots are a crucial tool in cancer treatment because of their precise targeting and control over cancer cells in the field of oncology. Cancer remains a major health challenge, which is leading to higher research into nanorobotic applications for oncology. In 2024, a major advancement in treating bladder cancer was revealed by scientists at the Institute for Bioengineering of Catalonia (IBEC), who utilized nanomachines powered by urea. In mice, these nanorobots were tested and were able to decrease tumor size by 90% after only one treatment, as they specifically attacked the tumor using a radioisotope attached to their surface.
3D-motion nanomachines focus on nanorobots capable of precise three-dimensional motion, which makes them essential for complex tasks in fields, including healthcare and manufacturing. Their ability to navigate intricate environments, such as human blood vessels or microfabrication systems, allows them to deliver drugs, repair tissues, or perform delicate procedures.
Bacteria-powered nanobots are a promising area in nanorobotics, where microorganisms are harnessed to power nanodevices. These nanobots are particularly useful in medical applications like cancer treatment, where they can be guided to tumors to deliver therapeutics. The bio-hybrid quality of these nanobots is being noticed because of their ability to move on their own, detect surroundings, and complete particular assignments, resulting in increased use in the fields of biotechnology and medicine.
Biochips are nanorobots used primarily for biological and chemical analysis, offering advanced diagnostic capabilities. Their integration into medical diagnostics is revolutionizing the detection of diseases at the molecular level, enabling faster, more accurate results. In 2024, Boston Micro Fabrication (BMF) introduced a new division called BMF Biotechnology Inc. that is dedicated to creating 3D BioChips for pharmaceutical and cosmetic studies. These innovative BioChips replicate human physiological conditions to enhance drug and cosmetic testing.
Nanorockets are a type of nanobot designed for high-speed propulsion in liquids. They are critical for targeted drug delivery and environmental monitoring, where their speed and precision allow for faster, more effective interventions.
Drug delivery holds the largest share of the industry
Drug delivery leads the market because of the increasing need for precision medicine and targeted therapeutic approaches. Nanorobots are being developed to transport medications straight to particular cells of tissues, improving treatment efficiency and reducing side effects. The growing prevalence of chronic diseases, coupled with the demand for less invasive treatments, is leading to the adoption of nanorobots in this area. According to the nanorobotics market forecast, the integration of nanorobots into drug delivery systems is revolutionizing the market by offering even more precise and efficient therapeutic solutions.
Hospitals are a major end user of nanorobotics, particularly for applications in surgery, drug delivery, and diagnostics. The use of nanorobots in hospitals allows for more precise procedures, such as less invasive surgeries and targeted therapies, which can reduce recovery times and improve patient outcomes.
Diagnostic centers are leveraging nanorobotics to enhance the speed and accuracy of disease detection, including at the molecular level. Nanorobots can perform complex diagnostic tasks, such as analyzing blood samples or detecting biomarkers for various diseases, leading to earlier and more accurate diagnoses. The increasing focus on personalized medicine and preventive care is encouraging the adoption of nanorobotic solutions in diagnostic centers.
Research laboratories are at the forefront of nanorobotics development, using them for advanced studies in biotechnology, molecular biology, and materials science. Nanorobots play a crucial role in experimental applications, such as drug testing, gene therapy research, and the development of new nanomaterials.
Others includes various specialized users of nanorobotics, such as academic institutions, industrial facilities, and environmental organizations. These entities utilize nanorobots for an array of applications, ranging from environmental monitoring to industrial manufacturing.
North America leads the market, accounting for the largest nanorobotics market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for nanorobotics.
North America represents the largest segment, driven by strong investment in nanotechnology research operations, along with a well-established healthcare infrastructure. The leadership of the region in technological innovation, particularly in biotechnology and medical devices, is encouraging the adoption of nanorobots across various applications. The growing demand for advanced medical treatments, coupled with supportive government initiatives, is offering a favorable nanorobotics market outlook in the region. In 2023, researchers from New York and Ningbo, China, announced the creation of 3D DNA nanorobots capable of self-replication, marking a notable advancement in DNA nanotechnology. These tiny robots, with the ability to fit 1,000 across the width of a sheet of paper, held potential applications in medicine and environmental clean-up. The research opened new possibilities for nanomanufacturing and programmable nanorobots, offering innovative solutions for both the healthcare and environmental sectors.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)